[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1990

Morphine-Induced Metabolic Changes in Human BrainStudies With Positron Emission Tomography and [Fluorine 18]Fluorodeoxyglucose

Author Affiliations

From the Addiction Research Center, National Institute on Drug Abuse (Drs London, Broussolle, Cascella, Sano, Herning, and Jaffe, Ms Rippetoe, and Mr Snyder), and Departments of Radiology (Drs Links, Wong, Dannals, and Wagner) and Anesthesiology (Dr Toung), The Johns Hopkins Medical Institutions, Baltimore, Md.

Arch Gen Psychiatry. 1990;47(1):73-81. doi:10.1001/archpsyc.1990.01810130075010
Abstract

• Morphine sulfate effects (30 mg, intramuscularly) on cerebral glucose utilization and subjective self-reports were examined in 12 polydrug abusers by positron emission tomography and [fluorine 18]fluorodeoxyglucose in a double-blind placebocontrolled crossover study. During testing, subjects sat with eyes covered, listening to white noise and "beep" prompts. Morphine significantly reduced glucose utilization by 10% in whole brain and by about 5% to 15% in telencephalic areas and the cerebellar cortex, assuming no contribution of hypercapnia. When the contribution of Paco2 (45 minutes after morphine was administered) was partialled out, significant morphine-induced reductions persisted in whole brain and six cortical areas. Irrespective of morphine, left-greater-than-right asymmetry occurred in the temporal cortex, and an interaction between hemisphere and drug was noted in the postcentral gyrus. In most cases, effects on glucose utilization were not significantly related to measures of euphoria.

×